Ptc Therapeutics (PTCT) Gross Margin (2016 - 2026)
Ptc Therapeutics (PTCT) reported Gross Margin of 93.39% for Q3 2026, up 0.87 percentage points from 92.52% a year earlier but down 1.09 percentage points from the prior quarter.
Powered by 
Analysis
Ptc Therapeutics (PTCT) Gross Margin (2016 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Ptc Therapeutics' Gross Margin came in at 93.20%, down 3.63 percentage points year-over-year; for FY2025, it was 97.28%, up 4.40 percentage points from FY2024.
- Gross Margin has a five-year change of +2.26 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 92.89% in FY2024 (-0.13 pp), 93.02% in FY2023 (-0.59 pp), 93.61% in FY2022 (-0.39 pp) and 94.00% in FY2021 (-1.03 pp).
- Five-year quarterly Gross Margin spans a low of 89.72% in Q1 2026 and a high of 98.91% in Q1 2025.
- Year over year, Gross Margin gained in six of the last eight quarters, with an average year-over-year change of +0.46 percentage points.
- The high point for year-over-year Gross Margin in five years was Q1 2025 (a gain of 5.92 percentage points); the low point was Q1 2026 (a drop of 9.19 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 94.47% (Q2 2026), 89.72% (Q1 2026) and 95.78% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Ptc Therapeutics | 5.36 Bn | -2.84 Bn | 334.14 Mn | 93.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 93.39% |
| Jun 30, 2026 | 94.47% |
| Mar 31, 2026 | 89.72% |
| Dec 31, 2025 | 95.78% |
| Sep 30, 2025 | 92.52% |
| Jun 30, 2025 | 93.62% |
| Mar 31, 2025 | 98.91% |
| Dec 31, 2024 | 92.36% |
| Sep 30, 2024 | 94.49% |
| Jun 30, 2024 | 91.68% |
| Mar 31, 2024 | 92.98% |
| Dec 31, 2023 | 90.52% |
| Sep 30, 2023 | 95.17% |
| Jun 30, 2023 | 94.05% |
| Mar 31, 2023 | 93.58% |
| Dec 31, 2022 | 93.49% |
| Sep 30, 2022 | 93.55% |
| Jun 30, 2022 | 94.18% |
| Mar 31, 2022 | 93.19% |
| Dec 31, 2021 | 94.36% |
API Access
Ptc Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=PTCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "PTCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=PTCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();